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An alternative function for human uncoupling protein 3:
protection of mitochondria against accumulation of
nonesterified fatty acids inside the mitochondrial
matrix
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ABSTRACT The physiological function of the human
uncoupling protein 3 UCP3, which was discovered in
1997, is unknown. Here we evaluate the available data
on human UCP3 expression and show that UCP3 is
up-regulated in situations where fatty acid delivery to
the mitochondria exceeds oxidative capacity, whereas
down-regulation of UCP3 is observed when oxidative
capacity is enhanced. With a surplus of fatty acid
delivery, accumulation of nonesterified fatty acids in
the cytoplasm is likely to occur. Although the inner
mitochondrial membrane provides a barrier for nones-
terified fatty acids, neutral nonesterified fatty acids can
partition into the phospholipid bilayer and flip-flop to
the other side of the membrane, where they can be
released into the mitochondrial matrix. Due to pH
differences, these nonesterified fatty acids will be pro-
tonated. Because fatty acid anions can neither be
metabolized inside the matrix or cross the inner mito-
chondrial membrane, accumulation of nonesterified
fatty acids inside the matrix might occur. Therefore, we
postulate that UCP3 is required for the outward trans-
location of fatty acids from the mitochondrial matrix.
In this way, UCP3 is involved in the protection of
mitochondria against accumulation of nonesterified
fatty acids inside the mitochondrial matrix.—Schrau-
wen, P., Saris, W. H. M., Hesselink, M. K. C. An
alternative function for human uncoupling protein 3:
protection of mitochondria against accumulation of
nonesterified fatty acids inside the mitochondrial ma-
trix. FASEB J. 15, 2497–2502 (2001)
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Due to their homology with ucp1, the recently
discovered human uncoupling proteins UCP2 and
UCP3 are suggested to play a role in human energy
metabolism and obesity (1–3). UCP2 and UCP3 encode
for proteins that are located in the inner mitochondrial
membrane, where they can uncouple respiration from
ATP production, thereby dissipating energy as heat.
When expressed in yeast, these uncoupling proteins
have been shown to lower the proton gradient across
the inner mitochondrial membrane (4–7), but the
mechanism by which they do so is under debate. It has
been proposed that UCPs either transport protons into
the mitochondrial matrix (8) or that the proton gradi-
ent is lowered by cycling of fatty acids in the inner
mitochondrial membrane, with a role for UCP in
transporting nonesterified fatty acid anions out of the
matrix (9). In contrast to UCP2, which is ubiquitously
expressed in virtually all tissues, UCP3 is restricted to
skeletal muscle and brown adipose tissue (10). In
humans, skeletal muscle is responsible for a major part
of energy expenditure and therefore UCP3 has been
implicated in the regulation of the latter. Since the
discovery of UCP3 in 1997, many data have been
published on the possible function of UCP3. Most data
have been obtained in cellular systems and/or animal
models and fewer have been obtained in humans.
Here we will review the available data in humans and
postulate a new function for the human uncoupling
protein 3.
IS HUMAN UCP3 INVOLVED IN
ENERGY EXPENDITURE?
Initially, research regarding the function of UCP3
focused on a possible role of UCP3 in energy expendi-
ture. Linkage and association studies have indeed sug-
gested a link between UCP3 and energy expenditure
(11, 12), although an absence of association between
UCP3 and energy expenditure has also been reported
(13). In Pima Indians, we found that the mRNA expres-
sion of UCP3 was positively correlated with sleeping
metabolic rate, which accounts for ;60% of total
energy expenditure in humans (14). To further exam-
ine whether UCP3 plays a role in energy expenditure,
we compared UCP3 mRNA levels in skeletal muscle of
endurance trained and untrained subjects. It is known
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that endurance training alters energy metabolism, with
trained subjects having an increased energy efficiency (15,
16). We found that endurance trained subjects had lower
amounts of UCP3 mRNA per mitochondria and UCP3
mRNA expression was highly correlated with (mechani-
cal) energy efficiency (17). Buemann et al. (18) recently
found an association between a polymorphism in the
UCP2 gene (which is close to the UCP3 gene) and
mechanical energy efficiency, which indirectly supports
the relation between UCP3 and energy efficiency. Indi-
rect evidence for a role of UCP3 in energy expenditure
comes from the finding that UCP3 mRNA and UCP3
protein are reduced after weight loss (19–21). Weight
reduction results in a decrease in basal metabolic rate,
even when expressed per unit of fat free mass, and it has
been proposed that this reduced energy expenditure is
responsible for the rapid weight regain observed in post-
obese subjects (22). Finally, Barbe et al. (23) reported that
treatment of lean subjects for 14 days with thyroid hor-
mone, known to increase metabolic rate, resulted in the
specific up-regulation of skeletal muscle UCP3 mRNA
expression. Together, these data do provide evidence for
a relation between skeletal muscle UCP3 and human
energy metabolism. Moreover, a role for UCP3 in energy
expenditure is underscored by the finding that mice
overexpressing UCP3 in skeletal muscle are hyperphagic
but weigh less than control mice (24). However, whether
the primary physiological function of UCP3 is the regula-
tion of energy expenditure is under debate. For example,
UCP3 knockout mice have normal energy expenditure
and are not obese (25, 26). In humans, fasting, a condi-
tion associated with energy conservation (27), results in
the up-regulation of UCP3 mRNA expression (28). These
data are thus inconsistent with a role for human UCP3 in
the regulation of energy expenditure and have urged
researchers to search for a new function for human
UCP3. Taken together, the available data show that UCP3
is related to human energy expenditure, but the primary
role of UCP3 does not seem to be directly related to the
regulation of energy expenditure.
IS HUMAN UCP3 INVOLVED IN FATTY
ACID METABOLISM?
An explanation for the unexpected up-regulation of
UCP3 during fasting comes from the observation that
free fatty acids (FFA) up-regulate UCP3 mRNA expres-
sion, both in rodents (29) and in humans (30). During
fasting and conditions of elevated plasma FFA levels,
however, fat oxidation is also increased, and it has
therefore been suggested that UCP3 is involved in the
handling of lipids as a fuel (31). Several studies have
been performed with humans to elucidate the potential
function of UCP3 in fatty acid metabolism.
Acute exercise and UCP3
During and after acute endurance exercise, energy
expenditure, plasma FFA levels, and fat oxidation are
rapidly increased. In rodents, a rapid up-regulation of
UCP3 after acute exercise was observed (32–34). In
humans, the effect of acute exercise on UCP3 expres-
sion has also been studied. We did not observe an effect
of 80 min of exhaustive cycling exercise on UCP3
mRNA expression measured immediately after the ex-
ercise bout (17). Pilegaard et al. (35) observed that
UCP3 mRNA was up-regulated 1 to 4 h after an acute
bout of exercise. In both studies, the possible effect of
plasma FFA levels on UCP3 expression was not ad-
dressed. Therefore, we recently investigated whether
the up-regulation of UCP3 mRNA expression after
acute exercise is an effect of exercise per se or an effect
of increased levels of plasma FFA (36). Subjects per-
formed a 2 h exercise bout twice, once in the fasted
state and once with the ingestion of glucose, and UCP3
mRNA expression was measured 1 and 4 h postexercise.
This protocol resulted in marked differences in plasma
FFA levels and fat oxidation during and after exercise
between the glucose-fed and fasted state. Four hours
after exercise, UCP3 mRNA was up-regulated, but only
in the fasted state. Therefore, the effect of exercise on
UCP3 mRNA expression is not an exercise effect per se
but an effect of elevated plasma FFA levels and/or
increased fat oxidation (36).
High-fat diets and UCP3
Another condition in which fatty acid metabolism is
affected is during the consumption of high-fat diets.
Prolonged consumption of a high-fat diet results in a
gradual increase in fat oxidation, without a change in
fasting plasma FFA levels (37). We examined the effect
of prolonged consumption of high-fat diet (60 en% as
fat) on UCP3 mRNA expression and found that UCP3
mRNA tended to increase after a 4 wk period of high-fat
diet consumption (38), consistent with data obtained in
rodents (29, 39). In-depth evaluation of the data
showed that the increase in UCP3 mRNA on the
high-fat diet was related to the subjects’ proportion of
type IIA muscle fibers, with the highest increase in
UCP3 mRNA in those subjects with the highest amount
of type IIA muscle fibers (38). Type IIA muscle fibers
are capable of oxidizing both carbohydrates and fatty
acids, whereas type I and IIB muscle fibers are enzymat-
ically equipped for the oxidation of fat and carbohy-
drate, respectively. These results led us to examine
whether UCP3 protein is differentially expressed in the
different muscle fibers. Surprisingly, we found that
UCP3 is abundantly expressed in type IIB muscle fibers,
moderately in type IIA fibers, and expressed to a much
lower extent in type I muscle fibers (40). High expres-
sion of UCP3 in type IIB muscle fibers, which are not
able to oxidize fatty acids, is inconsistent with a role for
UCP3 in the oxidation of fatty acids.
Endurance training
As we discussed above, endurance training is associated
with an increase in energy efficiency and a down-
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regulation of UCP3 expression. However, a typical
feature of endurance trained athletes is an increased fat
oxidation capacity (41). We recently performed a study
in which we examined the effect of a 3 month training
program in lean, untrained subjects on UCP3 expres-
sion and fat oxidation. Although muscle biopsies were
available only in five subjects, we found a significant
decrease in UCP3 protein after the training program
(Fig. 1A), whereas triglyceride-derived fat oxidation (as
determined by stable isotope tracer technique) was
increased and plasma FFA levels were unaltered (un-
published results). As shown in Fig. 1B, there was an
inverse relation between the change in UCP3 protein
and the change in fat oxidation: those subjects whose
fat oxidation capacity under standardized conditions
increased the most showed the most pronounced de-
crease in UCP3.
Weight reduction and thyroid hormone treatment
Two other conditions known to influence UCP3 expres-
sion are also associated with changes in fatty acid
metabolism. First, weight reduction has been shown to
decrease UCP3 expression, and this down-regulation of
UCP3 could be related to changes in energy expendi-
ture, as discussed above. However, fat oxidation capac-
ity is increased and plasma FFA levels are reduced after
weight reduction, raising the possibility that UCP3
content is related to these changes in fatty acid metab-
olism. Second, the specific up-regulation of UCP3 with
thyroid hormone treatment could not only be related
to the increase in metabolic rate, but thyroid treatment
also results in the stimulation of lipolysis and fat
oxidation (42).
In summary, these data show a relation between
human UCP3 content and fatty acid metabolism and
suggest a physiological role for UCP3 in fat metabolism.
IS UCP3 REGULATED BY PLASMA FFA LEVELS
AND/OR FAT OXIDATION?
So far, two explanations have been given for the
observed relation between UCP3 and fatty acid metab-
olism. The first explanation simply states that plasma
nonesterified fatty acids are ligands for PPARs, and the
PPARs have been shown to regulate UCP3 gene expres-
sion (43). A second explanation suggests a role for
UCP3 in the handling of lipids as a fuel (44). However,
both concepts fail to fully explain the data outlined
above. Although the up-regulation of UCP3 during
fasting, acute exercise, and thyroid treatment could be
attributed to an elevation of plasma nonesterified fatty
acid levels, the up-regulation of UCP3 after long-term
high-fat diet cannot necessarily be attributed to
changes in plasma FFA levels, since on the long-term
high-fat diet consumption does not increase fasting
plasma nonesterified fatty acid levels. Similarly, the
down-regulation of UCP3 with endurance training is
not accompanied by a reduction in plasma nonesteri-
fied fatty acid levels. Therefore, the relation between
UCP3 and fatty acid metabolism cannot be explained
solely by the effect of plasma nonesterified fatty acid
levels on UCP3. On the other hand, the explanation
that UCP3 is involved in the handling of lipids as a fuel
is not fully compatible with the available data. Weight
reduction and endurance training lead to an increase
in the capacity to oxidize fat whereas UCP3 is down-
regulated. Moreover, the fact that UCP3 protein ex-
pression is highest in type IIB muscle fibers, which are
hardly able to oxidize fatty acids, might be the most
direct evidence against a role for UCP3 in the handling
of lipid as a fuel.
AN ALTERNATIVE FUNCTION: UCP3 IS A
TRANSPORTER OF NONESTERIFIED FATTY
ACIDS OUT OF MITOCHONDRIA
As mentioned earlier, UCP3 could perform its uncou-
pling activity by transporting nonesterified fatty acid
anions across the inner mitochondrial membrane (9).
Oxidation of nonesterified fatty acids from cytoplasm
requires several subsequent steps to transport them
into the mitochondrial matrix where b-oxidation takes
place. In the cytoplasm, nonesterified fatty acids are
esterified to fatty acyl-CoA by an enzyme called fatty
acyl-CoA synthetase. Fatty acyl-CoA (but also nonesteri-
fied fatty acids) can easily cross the outer mitochondrial
membrane. However, the inner mitochondrial mem-
brane is impermeable for long-chain fatty acyl-CoA and
therefore, the acyl-CoA ester is converted to acyl-carni-
tine, by CPT1 located at the outer mitochondrial
membrane. Acyl-carnitine crosses the inner mitochon-
drial membrane and is reconverted to acyl-CoA in the
matrix by CPT2. Since only fatty acyl-CoA is able to
enter the b-oxidation, this sequence of steps is a
prerequisite for directing nonesterified fatty acids into
the mitochondrial matrix for oxidation.
Nonesterified fatty acids can easily cross the outer
mitochondrial membrane. Although the inner mito-
chondrial membrane provides a barrier for nonesteri-
fied fatty acids, neutral nonesterified fatty acids (but
not anions) can partition into the phospholipid bilayer
Figure 1. A) The effect of 3 months of endurance training on
UCP3 protein content (n55). *P , 0.05. B) The relation
(r50.93, P50.02, n55) between changes in fat oxidation and
UCP3 protein induced by endurance training.
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and can flip-flop to the matrix side of the membrane
(45, 46). Here, these neutral nonesterified fatty acids
could enter the mitochondrial matrix, where they will
be deprotonated due to the proton gradient across the
inner mitochondrial membrane. In this way, nonesteri-
fied fatty acids are able to lower the proton gradient
(uncoupling effect). Once in the matrix, the formed
nonesterified fatty acid anion cannot be converted to
fatty acyl-CoA due to lack of fatty acyl-CoA synthetase in
the matrix. Since nonesterified fatty acid anions are not
able to flip-flop back across the inner mitochondrial
membrane (46), nonesterified fatty acid anions would
accumulate inside the mitochondrial matrix. It is
known that in the mitochondrial matrix, nonesterified
fatty acids have deleterious effects on mitochondrial
function due, for example, to lipid peroxidation.
Therefore, these nonesterified fatty acids need to be
transported out of the mitochondrial matrix. Here
UCP3 could be involved in the outward translocation of
nonesterified fatty acids anions out of the mitochondria
(Fig. 2).
We hypothesize that the physiological function of
UCP3 is to protect mitochondria from accumulation of
nonesterified fatty acids inside the mitochondrial ma-
trix, especially in situations where fatty acid delivery
exceeds oxidation. We believe that, although the major
part of the nonesterified fatty acids delivered to mito-
chondria will be subject to oxidation, a small amount of
nonesterified fatty acids might reach the mitochondrial
matrix, and it is known that nonesterified fatty acids are
potentially toxic. The entrance of nonesterified fatty
acids inside the matrix may play a significant role in
situations where fatty acid supply to the mitochondria
does not match oxidation. Reevaluating the data de-
scribed above indeed shows that UCP3 is up-regulated
in situations where fatty acid supply exceeds fat oxida-
tion capacity (fasting, high-fat diet, T3 treatment, acute
exercise) whereas UCP3 is down-regulated in situations
where fat oxidation capacity is improved (endurance
training, weight reduction). The high expression of
UCP3 in type IIB muscle fibers is also consistent with
this hypothesis, since these muscle fibers, which are
barely able to oxidize fatty acids, especially need to be
protected against mitochondrial nonesterified fatty ac-
ids accumulation. Type I muscle fibers, on the other
hand have a high capacity to oxidize fatty acids and
therefore are less prone to accumulation of nonesteri-
fied fatty acids; thus, UCP3 content can be low. This
protective function of UCP3 is associated with the
outward translocation of nonesterified fatty acids an-
ions and therefore will decrease the proton gradient
across the inner mitochondrial membrane, thereby
uncoupling respiration from ATP production. Because
of this primary function of UCP3, UCP3 still indirectly
influences energy metabolism, explaining the relation
between UCP3 and energy metabolism.
In conclusion, we propose the hypothesis that the
primary function of UCP3 is the outward translocation
of nonesterified fatty acids from the mitochondrial
matrix, especially in situations when fatty acid supply
exceeds oxidation. Because of this function, UCP3
uncouples mitochondrial respiration, explaining its
relation with human energy metabolism.
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